Showing 1 - 10 of 259
Measuring consumer responsiveness to medical care prices is a central issue in health economics and a key ingredient in the optimal design and regulation of health insurance markets. We study consumer responsiveness to medical care prices, leveraging a natural experiment that occurred at a large...
Persistent link: https://www.econbiz.de/10012457037
levels of health care spending, controlling for past health care use. We estimate the demand elasticity of total health care …
Persistent link: https://www.econbiz.de/10012480373
Persistent link: https://www.econbiz.de/10012480808
, indicating more elastic demand around a zero price. We also find that increased utilization primarily reflects low-value and …
Persistent link: https://www.econbiz.de/10012480957
. Costly new technology, while often an improvement to existing care, has been identified as a principal driver of health care …
Persistent link: https://www.econbiz.de/10012482374
implications of deductibles that reset over shorter timespans. We develop a model of insurance demand between two actuarially …
Persistent link: https://www.econbiz.de/10012482646
reductions in demand affect only 'low-value' drugs; on the contrary, those at the highest risk of heart attack and stroke, who … different from the price elasticity of demand …
Persistent link: https://www.econbiz.de/10012482655
, however, considerably dampen demand. We find that uptake drops by 75 percent when the price of ITNs increases from zero to $0 …
Persistent link: https://www.econbiz.de/10012464241
We use a large data set of deductible choices in auto insurance contracts to estimate the distribution of risk preferences in our sample. To do so, we develop a structural econometric model, which accounts for adverse selection by allowing for unobserved heterogeneity in both risk (probability...
Persistent link: https://www.econbiz.de/10012467219
Insurance for prescription drugs is characterized by two types of cost-sharing: flat copayments and variable coinsurance. We develop a theoretical model to show that refill purchases of preventive drugs (compliance) are lower under coinsurance due to the consumer's exposure to variation in drug...
Persistent link: https://www.econbiz.de/10012467952